STUDY

Minoxidil pills did not clearly beat Rogaine on the scalp

“Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.” Penha MA et al. JAMA Dermatology. June 2024

Penha MA et al. · JAMA Dermatology · June 2024

Randomized controlled trial
The finding

Over 24 weeks, 5 mg oral minoxidil did not clearly beat 5% topical minoxidil on the main hair-density measure in men with pattern hair loss.

Type of study

Where this study sits on the evidence spectrum

Some kinds of studies are much more reliable than others. Studies further right do more to rule out chance and bias.

Weaker evidenceStronger evidence
Lab or animal studyCase reportCase seriesCohort studyRandomized trialMeta-analysis
Randomized and double-blind. Everyone took a pill and used a scalp solution, but only one contained minoxidil. This helped keep participants and study staff from knowing who got which treatment.
At a glance

Who was studied and for how long

Enrolled
90 men
68 completed the study
Length
24 weeks
One clinic in Brazil
Condition
Pattern hair loss
Men ages 18 to 55
Compared
Oral vs topical
5 mg pill vs 5% scalp solution
What they did

How the study worked

90 menpattern hair lossRANDOMSPLITOral minoxidil45 assigned5 mg dailyTopical minoxidil45 assigned5% twice dailyMEASURED ATWeek 24scalp hair counts90 menpattern hair lossRANDOMSPLITOral minoxidil45 assigned · 5 mg dailyTopical minoxidil45 assigned · 5% twice dailyMEASURED ATWeek 24scalp hair counts
Random assignment45 men started in each group.
Pill and solutionOne group took 5 mg by mouth daily. The other applied 1 mL of 5% solution twice daily. Each also received a dummy version of the other treatment.
Hair countsThe study counted thicker hairs at the front and crown of the scalp at baseline and week 24.
What they found

The results

Oral minoxidilTopical minoxidil

Visible improvement at the crown

Share judged improved from photos; this was separate from the main hair-density measure.

Oral minoxidil
70%
Topical minoxidil
46%
Secondary outcome (p = 0.04)

Excess hair growth

Reported in 22 of 45 on oral minoxidil and 11 of 45 on topical minoxidil.

Oral minoxidil
49%
Topical minoxidil
25%
p = 0.02
The main comparison counted thicker hairs per square centimeter. The estimated difference favored the pill by 3.1 thicker hairs per square centimeter at the front (p = 0.27) and 23.4 at the crown (p = 0.09), but both estimates were imprecise. Photos favored the pill at the crown, but that was a separate measure.
Who paid for it

Funding and conflicts of interest

The Brazilian Dermatology Society Support Fund funded the trial and had no role in conducting or reporting it. The lead author reported a grant from the fund.

How much to trust it

Strengths and limits

Strengths

  • Randomized and double-blind
  • Compared two active treatments directly
  • Used standardized scalp images for hair counts

Limits

  • Only 68 of 90 men completed the study
  • One clinic, with 24 weeks of follow-up
  • The trial tested one oral dose and one topical schedule in men
  • Too small to compare uncommon side effects reliably
Moderate confidence. The blinded comparison was useful, but 22 men did not finish and the hair-count estimates were imprecise.
What it means for you

The takeaway

No clear hair-count winner

The trial did not establish a hair-density advantage for the pill, and excess hair growth was reported more often with it.

These results do not establish that the treatments are equivalent or apply to lower oral doses.

Pages that cite this study

Read more on Dermapedia

Terms in this study

Words worth knowing

Terminal hairs

The thicker hairs that make up most visible scalp coverage.

Placebo

A pill or solution that looks like the treatment but has no active drug.

Original source

Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.. JAMA Dermatol. 2024;160(6):600-605.

PMID 38598226